TY - JOUR
T1 - Efficacy of Care and Antibiotic Use for Chalazia and Hordeola
AU - Alsoudi, Amer F.
AU - Ton, Lauren
AU - Ashraf, Davin C.
AU - Idowu, Oluwatobi O.
AU - Kong, Alan W.
AU - Wang, Linyan
AU - Kersten, Robert C.
AU - Winn, Bryan J.
AU - Grob, Seanna R.
AU - Reza Vagefi, M.
N1 - Publisher Copyright:
© 2022 Lippincott Williams and Wilkins. All rights reserved.
PY - 2022/4/1
Y1 - 2022/4/1
N2 - Objectives:To evaluate whether use of an antibiotic improves the efficacy of care for a chalazion or hordeolum.Methods:A cross-sectional retrospective review was performed. All patients treated for a newly diagnosed chalazion or hordeolum at the University of California, San Francisco from 2012 to 2018 were identified. Patients were excluded when clinical notes were inaccessible or there was inadequate documentation of treatment modality or outcome. Patient demographics, setting of initial presentation, treatment modalities, antibiotic use, and outcomes were analyzed.Results:A total of 2,712 patients met inclusion criteria. Management with an antibiotic was observed in 36.5% of patients. An antibiotic was 1.53 times (95% confidence interval [CI], 1.06-2.22, P=0.025) more likely to be prescribed in emergency or acute care setting for a chalazion. Older age was associated with a higher risk of receiving an antibiotic for a hordeolum (adjusted RR 1.07 per decade, 95% CI, 1.05-1.11, P<0.001). The addition of an antibiotic to conservative measures for a chalazion (adjusted RR, 0.97, 95% CI, 0.89-1.04, P=0.393) or hordeolum (adjusted RR, 0.99, 95% CI, 0.96-1.02, P=0.489) was not associated with an increased likelihood of treatment success.Conclusion:Although frequently prescribed, an antibiotic is unlikely to improve the resolution of a chalazion or hordeolum.
AB - Objectives:To evaluate whether use of an antibiotic improves the efficacy of care for a chalazion or hordeolum.Methods:A cross-sectional retrospective review was performed. All patients treated for a newly diagnosed chalazion or hordeolum at the University of California, San Francisco from 2012 to 2018 were identified. Patients were excluded when clinical notes were inaccessible or there was inadequate documentation of treatment modality or outcome. Patient demographics, setting of initial presentation, treatment modalities, antibiotic use, and outcomes were analyzed.Results:A total of 2,712 patients met inclusion criteria. Management with an antibiotic was observed in 36.5% of patients. An antibiotic was 1.53 times (95% confidence interval [CI], 1.06-2.22, P=0.025) more likely to be prescribed in emergency or acute care setting for a chalazion. Older age was associated with a higher risk of receiving an antibiotic for a hordeolum (adjusted RR 1.07 per decade, 95% CI, 1.05-1.11, P<0.001). The addition of an antibiotic to conservative measures for a chalazion (adjusted RR, 0.97, 95% CI, 0.89-1.04, P=0.393) or hordeolum (adjusted RR, 0.99, 95% CI, 0.96-1.02, P=0.489) was not associated with an increased likelihood of treatment success.Conclusion:Although frequently prescribed, an antibiotic is unlikely to improve the resolution of a chalazion or hordeolum.
KW - Antibiotic
KW - Antibiotic resistance
KW - Antibiotic stewardship
KW - Chalazion
KW - Hordeolum
UR - http://www.scopus.com/inward/record.url?scp=85126677899&partnerID=8YFLogxK
UR - http://www.scopus.com/inward/citedby.url?scp=85126677899&partnerID=8YFLogxK
U2 - 10.1097/ICL.0000000000000859
DO - 10.1097/ICL.0000000000000859
M3 - Article
C2 - 35296627
AN - SCOPUS:85126677899
SN - 1542-2321
VL - 48
SP - 162
EP - 168
JO - Eye and Contact Lens
JF - Eye and Contact Lens
IS - 4
ER -